Results 141 to 150 of about 34,183 (229)

Reversible Effects of Integrase Inhibitors on Newly Differentiated Adipocytes. [PDF]

Viruses
Pickering RT, Asundi A, Olson A, Soden K, Lin NH.   +4 more
europepmc   +1 more source

Integrase Inhibitors are Associated with Neuropsychiatric Symptoms in Women with HIV. [PDF]

J Neuroimmune Pharmacol, 2023
Rubin LH, O'Halloran JA, Williams DW, Li Y, Fitzgerald KC, Dastgheyb R, Damron AL, Maki PM, Spence AB, Sharma A, Gustafson DR, Milam J, Weber KM, Adimora AA, Ofotokun I, Fischl MA, Konkle-Parker D, Xu Y.   +17 more
europepmc   +1 more source

Weight Gain and Metabolic Effects in Persons With HIV Who Switch to ART Regimens Containing Integrase Inhibitors or Tenofovir Alafenamide. [PDF]

J Acquir Immune Defic Syndr, 2023
Palella FJ, Hou Q, Li J, Mahnken J, Carlson KJ, Durham M, Ward D, Fuhrer J, Tedaldi E, Novak R, Buchacz K.   +10 more
europepmc   +1 more source

Real-world experience with weight gain among pregnant women living with HIV who are using integrase inhibitors. [PDF]

HIV Med, 2023
Fuller T, Fragoso da Silveira Gouvêa MI, Benamor Teixeira ML, Ferreira Medeiros A, Amorim da Silva P, Medeiros Braga C, Constan Werneck Sant'anna M, de Mattos Salgueiro M, da Silveira Bressan C, Mendes-Silva W, João EC.   +10 more
europepmc   +1 more source

Different Trends of Immune Activation Markers When Switching to Either Oral or Injectable Dual Antiretroviral Therapy Based on Integrase Inhibitors in People Living with HIV. [PDF]

Pathogens
Vassallo M, Durant J, Fabre R, Capeau J, Fellahi S, Bastard JP, Corbeau P, Pradier C.   +7 more
europepmc   +1 more source

Reduction of CD8 T Cell Functionality but Not Inhibitory Capacity by Integrase Inhibitors. [PDF]

J Virol, 2022
Richter E, Bornemann L, Korencak M, Alter G, Schuster M, Esser S, Boesecke C, Rockstroh J, Gunzer M, Streeck H.   +9 more
europepmc   +1 more source

Development and Validation of a Machine Learning Model for Identifying Novel HIV Integrase Inhibitors. [PDF]

Cureus
Mukuhlani BT.
europepmc   +1 more source

Prevalence of resistance mutations associated with integrase inhibitors in therapy-naive HIV-positive patients in Baoding, Hebei province, China. [PDF]

Front Genet, 2022
Fan W, Wang X, Zhang Y, Meng J, Su M, Yang X, Shi H, Shi P, Lu X.   +8 more
europepmc   +1 more source

Experience of a Nationwide implementation of single-tablet second-generation integrase inhibitors-based treatment in Mexico. [PDF]

IJID Reg
Piñeirúa-Menéndez A, Caro-Vega Y, Mosqueda-Gómez JL, Ríos SÁ, Badial-Hernández F, la Torre-Rosas A, Sierra-Madero J.   +6 more
europepmc   +1 more source

Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors. [PDF]

AIDS
Russo SC, Ockene MW, Arpante AK, Johnson JE, Lee H, Toribio M, Stanley TL, Hadigan CM, Grinspoon SK, Erlandson KM, Fourman LT.   +10 more
europepmc   +1 more source